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Immune-mediated myocyte injury can occur during rejection of the transplanted heart, as a consequence of viral myocarditis, and possibly contributes to cardiac dysfunction in patients with dilated cardiomyopathy. Injury may be reversible and manifest as a transient depression of ventricular function and/or electrophysiological stability, or it may be irreversible and lead ultimately to myocyte necrosis and progressive chronic congestive heart failure and/or death. The injury process may be primarily directed at vascular cells, in which case myocyte injury may be secondary to impairment of delivery of oxygen and substrates, or the process may directly involve the cardiac myocyte, in which case the injury is primary. Cellular and humoral components of the immune system may participate in both primary and secondary as well as reversible and irreversible injury.
In this discussion, we will review work that has contributed to our current understanding of the mechanisms by which myocyte injury occurs in different clinically significant conditions. We will focus primarily on the types of immune effector cells involved and the mechanisms by which they appear to damage myocytes because there is more recent information available on these topics. However, humoral processes also will be considered. From a clinical standpoint, prevention of initiation of an immune response against the heart is undoubtedly the most desirable means of reducing immune-mediated myocyte injury; however, this is not always feasible or possible. An understanding of the injury processes involved may result in better interventions to modify and/or reduce cardiac damage.
Functional Changes in the Intact Heart
During Immune-Mediated Injury Changes in systolic and diastolic function in the intact heart have been documented to occur during cardiac transplant rejection and myocarditis. Studies in both experimental animals and humans'-" have shown that hemodynamic deterioration can occur coincident with allograft rejection and is correlated with the degree of lymphocyte infiltration and the extent of myocyte necrosis. Abnormalities in systolic function during rejection are frequently present. For example, Hansen et a13 found that the peak left ventricular filling rate was not changed during rejection, but that end-systolic volume was increased. The systolic dysfunction that occurs during rejection may also be reversed by treatment of the rejection process. For example, Stevenson et a15 reported a transplant recipient with acute left ventricular dysfunction and cardiogenic shock that was associated with only mild histological changes. Left ventricular function in this case improved rapidly after treatment with intravenous steroids and gradually returned to normal. de Marchena et a19 described a patient with severe, reversible right ventricular systolic dysfunction during acute rejection. Myles et a16 have demonstrated that the ultrastructural changes associated with rejection and indicative of myocyte injury were also reversible with treatment.
Abnormalities in diastolic function may also occur during rejection. Davies et a12 found elevated diastolic filling pressures early after transplant in a number of patients in whom the ejection fraction, measured with radionuclide techniques, remained in the normal range. They suggested that the hemodynamic changes observed were more compatible with "restriction" of ventricular filling and that an abnormality of diastolic compliance might be involved. Czerska et a17 found that rejection in patients was associated with a decreased normalized peak rate of left ventricular posterior wall thinning and a decreased diastolic mitral valve slope, whereas systolic function, as defined by fractional shortening, was not altered. They also concluded that the rejection process resulted in impaired ventricular diastolic compliance without changes in systolic function.
Amende et al'0 found no changes in ejection fraction or end-systolic volume during acute rejection; end-diastolic volume decreased, as did peak diastolic filling rate. Fig 1) . Adhesion of the T cell to the antigen-presenting cells or target cell is facilitated by specific adhesion molecules such as lymphocyte function-related antigen (LFA)-3 and CD2, and intracellular adhesion molecule-1 (ICAM-1) and LFA-1, which will be discussed later. Table 1 , References 28 through 33). 43 The mechanisms by which pore-forming proteins result in target cell lysis are not completely understood. As reviewed by Henkart,44 one theory is that pore-forming proteins, when inserted into the plasma-lemma, cause "colloid osmotic lysis" of the cell due to a selective increase in membrane permeability of the target cell to small ions, with dissipation of transplasmalemmal ionic concentration gradients. The macromolecules inside the cell then exert an unbalanced osmotic pressure across the membrane, causing the cell to rupture and release cytoplasmic contents. Although this mechanism seems to account for lysis of some target cells, this may not be the primary mechanism for all target cells.
For example, Ostergaard and Clark45 have reported that some CTL can kill one target cell in the absence of Ca2' and yet require Ca2+ for lysis of another. More recent work from this group46 has shown that 4,4'-diisothiocyano-2,2' disulfonic acid (DIDS), which inhibits degranulation, does not inhibit Ca2+-dependent lytic activity in some CTL. Takayama and Sitkovsky47 have also suggested that T-cell receptor-triggered exocytosis of cytolytic granules may not be required for target cell lysis by CTL, and Young et alW have suggested that there may be multiple mediators that are acting in concert or independently in CTL-induced cell killing. Sanderson49 used time-lapse photography to study target cells during attack by cytotoxic T cells. He described "zeiosis," or target cell membrane blebbing, which occurred at a variable time before cell lysis. He proposed that zeiosis may result from massive changes in the cytoskeletal system. Zeiosis is not seen in time-lapse studies of killing of antibody-coated tumor cells by complement-mediated lysis, which is also believed to occur by colloid osmotic lysis induced by pore formation. Liu et al50 have shown evidence that murine CTL contain a cytolytic factor other than perforin. The factor is antigenically related to TNF and lymphotoxin and requires several hours to induce maximal lytic activity, which may be due to DNA fragmentation. The presence of target cell membrane blebbing, cytoskeletal alterations, and DNA fragmentation is consistent with CTLinduced apoptosis, or "programmed cell death."'51 This process is characterized by activation of a nonlysosomal Ca2+/Mg 2k-dependent endonuclease, which gives rise to a characteristic "ladder" pattern on DNA electrophoresis. However, it appears that genome digestion is not absolutely required for CTL-mediated target cell death by an apoptosis mechanism.52
Thus, CTh as well as cellular components of a DHT reaction can certainly cause target cell lysis, although the mechanisms of killing may vary with the target cell type and the nature of the CTL. We will now consider whether these cellular components of the immune system contribute to indirect (due to vascular effects) and direct myocyte damage. Table 1 and Fig 1) .24,53-56 These adhesion molecules interact with receptor molecules on the surface of circulating monocytes and neutrophils. For ICAM-1 the receptor is LFA-1 (also called CD11a/CDi8 and aL/32-integrins). The specific receptors on the lymphocyte for P-selectin (and E-selectin, also known as endothelialleukocyte adhesion molecule-1) remain unidentified53 (see Fig 1) .
The expression of these molecules on lymphocytes promotes their activation and adherence to, followed by migration through, the endothelium.54-56 The endothelium can be injured by locally high concentrations of cytokines and by natural killer lymphocytes, CTL, and possibly by HTL.53 This ultimately results in the development of an "inflammatory" endothelium,57 with leakage of albumin and other macromolecules into the interstitium documented to occur early in the rejection process.5859 It is also noteworthy that increased expression of endothelial-cell human class II MHC antigen (HLA-DR) has been noted to occur in some patients with dilated cardiomyopathy60 and myocarditis. 61 It is likely that interstitial edema resulting from endothelial injury increases wall thickness and perhaps accounts for the decrease in ECG voltage frequently noted during rejection episodes. It may also be the cause of decreased ventricular chamber compliance, resulting in an increase in filling pressures. It is also apparent that chronic vascular injury can occur after cardiac transplantation.59 This can result in functional changes such as impaired endothelial celldependent vasodilatation62 and eventual small-vessel obstruction and large epicardial coronary artery atherosclerosis. 63 The resulting obstructive coronary artery lesions can cause myocyte dysfunction and necrosis as a result of impaired delivery of oxygen and substrates (ischemia). Although immune-mediated vascular injury is of enormous clinical importance, particularly in allograft rejection, the major focus of this discussion is the causes of direct myocyte injury.
Cell-Mediated Direct Myocyte Injury
We shall now consider the evidence that CTL, cytokines, and components of the DHT response can cause direct myocyte injury and/or dysfunction.
Cytotoxic T Lymphocytes
Traditionally, it has been believed that CD8+ CTLmediated lysis of parenchymal (and possibly vascular) cells is a very important mechanism of tissue injury during allograft rejection. As Most of the studies of CTL-mediated cytotoxicity have been carried out using lymphoblast cells as a target; however, it is quite likely that the nature of the injury produced may depend on the type of target cell studied69 and that parenchymal cells may be more resistant to CTL-mediated injury than lymphoblasts. be attributed to donor-specific CTL, as well as antibody-dependent lymphocyte-mediated cytotoxicity. However, the degree of cytotoxicity assayed against lymphocyte target cells was relatively low (~30% lysis at 100:1 effector-to-target ratio) and showed only modest allogeneic specificity (1% to 6%). Furthermore, in these studies the effectorinfiltrating cell population was centrifuged in a FicollHypaque gradient that would tend to remove neutrophils. Thus, the possible contribution of this cell type to cell injury may have been underestimated.
Cells infiltrating a rejecting murine heart may be harvested by collagenase treatment. 84 We have examined the cytotoxicity of these "heart-infiltrating cells" (HIC) against cultured adult and fetal mouse myocytes. The cells making up the HIC population are shown in Table 2 . The population consists primarily of lymphocytes, macrophages, and neutrophils. In preliminary experiments,85 we have found that, although the HIC population contains a similar number of CTL, the injury of myocytes produced by HIC cells differs markedly from that produced by mixed lymphocyte reaction cells. The latter, as previously described,75 appears to be due entirely to the CD8+ (CTL) component. Injury produced by HIC is less intense and does not appear to be allospecific, in that self and third-party strains of myocytes are injured as severely as allospecific target cells. This finding suggests that although CTL are certainly present in the rejecting heart, they appear functionally relatively ineffective in producing cytotoxicity against myocyte target cells, and injury produced by HIC may also result from other nonallospecific mechanisms. These results are consistent with a recent report by Bishop et al86 in which the effects of in vivo depletion of mice of CD8+ cells on rejection of a heterotopic allograft were examined. These investigators found that although depletion of CD8+ cells virtually eliminated CTL from the infiltrating cell population (estimated by limiting dilution analysis), rejection of the graft occurred in a normal fashion. This finding also raises the possibility that cells other than CD8+ CTL are effecting injury of the rejecting transplanted heart. We will now consider the cell types and mechanisms that could be involved and the evidence favoring their importance.
Macrophages and Neutrophils
As shown in Table 2 and discussed previously, a variety of cell types besides CTL are present in the HIC population, including HTL, macrophages, and neutrophils. We have previously shown that CD4+ HTL present in a mixed lymphocyte reaction do not induce lysis of cultured fetal mouse myocytes.75 Early work by Christmas and MacPherson87,88 showed that macrophages infiltrating a rejecting rat heart were not able to cause cultured myocyte lysis as detected by 51Cr release, although macrophages were able to inhibit spontaneous contractions of myocytes. The results of Strom et a182 also suggest that macrophages obtained from rejecting hearts have a relatively small cytolytic effect. Thus, cell types other than HTL or macrophages in the total HIC population must be considered as potential causes of myocyte lysis.
As previously discussed, natural killer cell and antibody-dependent cell-mediated cytotoxicity may be produced during allograft rejection. It is also possible Entman and associates90 have shown that the adhesion of isolated human neutrophils to adult canine myocytes is increased by the induction of expression of the intercellular adhesion molecule ICAM-1 on the myocyte surface by exposure to TNF-a, IL-1, and IL-6. Adhesion results from the interaction of myocyte ICAM-1 with CD11/CD18 integrins expressed on the surface of activated neutrophils, and the resulting neutrophil-myocyte interaction results in neutrophilinduced oxidative injury followed by contracture of the myocyte,91 (Fig 3) . Interestingly, the oxidative injury is intracellular and is not prevented by extracellular free radical scavengers, but is inhibited by monoclonal antibodies to ICAM-1, CD11b or CD18, or by intracellular radical scavengers. It is also important to note that low concentrations (< 10 U/mL) of cytokines were sufficient in these studies to induce adhesion molecule expression on the surface of adult myocytes.92 The significance of these findings in relation to ischemia-reperfusion injury has been emphasized,91 but they may be also relevant to myocyte injury in immune processes. Isobe et a193 have recently reported that survival of murine cardiac allografts can be markedly prolonged by treatment of recipient animals with monoclonal antibodies against ICAM-1 and LFA-1 (CD11a/CD18). Interestingly, the monoclonal antibody treatment did not completely prevent the initial leukocyte infiltrate but inhibited myocyte necrosis. Monoclonal antibody treatment in this report also induced prolonged tolerance. It is possible that the prevention of myocyte necrosis noted in this model is due to inhibition of the interaction between neutrophils and myocytes as well as to interference with ICAM-1-dependent, T lymphocyte-mediated effects. As free radicals can also cause reversible and irreversible depression of myocyte function,94-96 it seems possible that neutrophil-mediated injury could contribute to functional abnormalities of the ventricle during inflammation associated with myocarditis or rejection as well. However, direct experimental evidence that neutrophils participating in a DHT reaction cause myocyte injury is not available at present.
Effects of Cytokines
Although macrophages and HTL infiltrating a rejecting heart do not appear likely to be capable of directly causing myocyte necrosis, they could contribute to the alterations in contraction and relaxation observed during immune-mediated myocyte injury by production of cytokines. A variety of cytokines recently have been shown to have effects on myocytes, but considerable differences have been described regarding whether a direct negative inotropic effect or only a blunting of the effects of catecholamines is produced, and whether the effects are due to stimulation of nitric oxide (NO) production. For (Fig 5) . Brady 24 hours with C3H cytotoxic T lymphocytes (CTL) produced in a mixed lymphocyte reaction (MLR) (left) or in 1000 U/mL of interleukin (IL)-2, tumor necrosis factor-a, interferon-y, and IL-4 (right). Even these high concentrations of cytokines had no effect on survival of myocytes, whereas CTL caused virtually complete lysis of myocytes in an allospecific fashion (means+SEM, n=4).
Barry Immune-Mediated Myocyte Inijury 2429 nisms involved remain incompletely defined. Also, the concentrations of different cytokines in the microenvironment of the cardiac myocyte during myocarditis and allograft rejection are not known, making it difficult to relate in vitro effects noted at high cytokine concentrations to in vivo functional alterations.
While the above discussion certainly indicates that cytokines can alter function of myocytes, it does not appear likely that they can cause myocyte necrosis. The lack of an effect of HTL and macrophages in causing myocyte lysis has been mentioned above. In addition we have examined the effects of cytokines on survival of cultured adult mouse ventricular myocytes. As shown in Fig 6 , in this in vitro model, high concentrations of IL-1, TNF-a, INF-y, and IL-4 had no effect on myocyte survival over 24 hours relative to survival of control myocytes, whereas CTL from a mixed lymphocyte reaction caused virtually 100% killing.
Humoral Mechanisms of Injury
The major mechanism of cell injury mediated by the humoral or antibody-dependent component of the immune system is via the activation of complement via the classic pathway involving binding of the 112 have described the presence of autoantibodies against the (3adrenergic receptor in patients with dilated cardiomyopathy that may alter catecholamine responsiveness. Autoantibodies against other intracellular antigens such as myosin and heat-shock proteins have also been described,13 but the pathophysiological significance of these antibodies is not supported by experimental evidence at this time.
Summary
Much progress has been made in defining the mechanisms by which altered systolic and diastolic function of the heart may be produced by components of the immune system activated during allograft rejection and myocarditis and in patients with dilated cardiomyopathy. It is clear that injury of the vascular bed can occur via both humoral and cellular mediators and probably accounts for the acute alterations in ventricular compliance that occur during allograft rejection, as well as the accelerated development of graft atherosclerosis. Altered myocyte function and lysis can be produced by CTL in vitro, but the importance of this injury process in vivo remains uncertain. Other cells present in the inflammatory infiltrate can also affect myocyte function and survival. Neutrophils may cause lysis of myocytes, and cytokines produced by infiltrating macrophages and HTL may reach a sufficient concentration in the interstitial microenvironment to decrease myocyte catecholamine responsiveness and/or directly depress myocyte contractility. Humoral antibodies to myocyte cell surface antigens may cause cell damage by an antibody-dependent cytotoxic cell mechanism or by directly binding to and altering sarcolemmal receptor and/or ion channel function. Further elucidation of the extent of involvement of these different mechanisms in specific clinical settings may provide a basis for improved therapy of immune-mediated cardiac injury and dysfunction.
